| Program
  	
	      		
    	
        	
    	      	
    	        	
    	          		| Time | Event |  |  
        	          	| 09:00 - 09:15 | Welcome, Introduction to the workshop - Michel Khrestchatisky, François Féron/Frederic Chavane, Roisin Owens |  |  
        	          	| 09:15 - 10:00 | How the blood-brain barrier controls xenobiotics permeability - Pr. Jean-Michel Scherrmann, Faculty of Pharmacy, Paris, France |  |  
        	          	| 10:00 - 10:45 | Overcoming the Blood-Brain Barrier - The Extra Challenge for CNS Drug Development  - Dr. Christopher Untucht, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany |  |  
        	          	| 10:45 - 11:15 | Coffee break |  |  
        	          	| 11:15 - 12:00 | The BBB in cerebrovascular dysfunction and seizure disorders  - Dr. Nicola Marchi, Institute of Functional Genomics, Montpellier, France |  |  
        	          	| 12:00 - 12:45 | MicroRNAs in inflammation and ageing at the blood-brain barrier  - Pr. Nacho Romero, The Open University, Milton Keynes, UK |  |  
        	          	| 12:45 - 14:00 | Lunch |  |  
        	          	| 14:00 - 15:00 | In vitro models of the BBB: From Animal to Human - Pr. Roméo Cecchelli, Université d’Artois, Lens, France |  |  
        	          	| 15:00 - 16:00 | CNS drug delivery via Receptor Mediated Transport/Transcytosis - Dr. Michel Khrestchatisky, NICN, CNRS, Marseille, France |  |  
        	          	| 16:00 - 16:30 | Coffee break |  |  
        	          	| 16:30 - 17:30 | Innovative conducting polymer solutions for monitoring the blood brain barrier - Dr. Roisin Owens, Center of Microelectronics of Provence, Gardanne |  |  
        	          	| 17:30 - 18:00 | Closing remarks by students |  |  
        	
        		
        		   Tuesday, October 25, 2016        	    
        	 
        	
    	      	
    	        	
    	          		| Time | Event |  |  
        	          	| 09:15 - 10:15 | Patenting Biotech innovations - Philippe Becker, European Patent Attorney, founder & managing partner of Becker&Associes, Paris and Aix-en Provence, France |  |  
        	          	| 10:15 - 10:45 | Coffee break |  |  
        	          	| 10:45 - 11:45 | Managing IP in a Biotech - Lukas Voellmy, European Patent Attorney, IP Director at Innate Pharma Biotech company, Marseille, France |  |  
        	          	| 11:45 - 12:45 | Drafting & analysing a patent application - Pr. Peter Follette from Université Nice Sophia Antipolis, Nice, France |  |  
        	          	| 14:00 - 17:30 | Telling a clear scientific story in writing or in oral presentations - Pr. Peter Follette from Université Nice Sophia Antipolis, Nice, France |  |  
        	
        		
        		   Wednesday, October 26, 2016        	    
        	 
        	
    	      	
    	        	
    	          		| Time | Event |  |  
        	          	| 09:15 - 12:45 | Funding for research Workshop; Writing convincing grant applications - Dr. David Karlin, COSENS Entrepreneurs, Marseille, France |  |  
        	          	| 12:45 - 14:00 | Lunch |  |  
        	          	| 14:00 - 17:30 | Job search Workshop; Transforming your skills into an offer of services to boost your job search - Dr. David Karlin, COSENS Entrepreneurs, Marseille, France |  |  
        	
        		
        		   Thursday, October 27, 2016        	    
        	 
        	
    	      	
    	        	
    	          		| Time | Event |  |  
        	          	| 09:15 - 10:15 | TBA - Dr. Guillaume Jacquot, Vect-Horus, Marseille, France |  |  
        	          	| 10:15 - 10:45 | Coffee break |  |  
        	          	| 10:45 - 11:45 | TBA - Dr. Pascaline Lécorché, Vect-Horus, Marseille, France |  |  
        	          	| 11:45 - 12:45 | Realization of new ideas - Dr. Jacques Souquet, CEO SuperSonic Imagine, Aix-en-Provence, France |  |  
        	          	| 12:45 - 14:00 | Lunch |  |  
        	          	| 14:00 - 15:00 | Creating a biotech: The case of Iproteos - Dr. Laura Mendieta & Dr. Roger Prades, Iproteos, Barcelona, Spain |  |  
        	          	| 15:00 - 16:00 | Clinical development plans for CNS drugs  - Dr. Olivier Blin, Head Pharmacology Clinic, Hospital Timone, Marseille, France |  |  
        	          	| 16:00 - 16:30 | Coffee break |  |  
        	          	| 16:30 - 17:30 | The discovery and development of olesoxime for SMA:  a CNS bench to bedside success story - Dr. Rebecca Pruss, Former CSO Trophos, Marseille, France, Founder & director Windhover Biomed, London, UK |  |  
        	          	| 17:30 - 18:00 | Closing remarks by students |  |  
        	          	| 18:00 - 18:15 | Summary and farewell - Michel Khrestchatisky, Grigorios Kyriatzis |  |  |